Sarah L. Morgan, MD, MS, RD, FADAProfessor
Medical Director, Osteoporosis Clinic, Center for Metabolic Bone Disease

830 Faculty Office Tower
510 20th Street South
Birmingham, AL 35294-3408
Telephone: (205) 934-3235
Fax :(205) 934-4602


BS (Nutrition and Dietetics), Iowa State University, 1977
BS (Nutrition and Related Sciences), Iowa State University, 1977
MD, The University of Iowa, 1981
Internship and Residence (Internal Medicine), University of Iowa Hospitals and Clinics, Iowa City, 1981-1984
Fellowship (Clinical Nutrition), The University of Alabama at Birmingham, 1984-1986
MS (Nutrition), The University of Alabama at Birmingham, 1987  


C.E. Butterworth Award, UAB - 1986
Outstanding Young Alumna, Iowa State University, 1991
Outstanding Young Alumna, UAB Department of Nutrition Sciences, School of Health Related Professions
Distinguished Achievement Citation, Iowa State University, 1999
Outstanding UAB Woman Faculty Member, 2001
Distinguished Alumlnus Award for Achievement, University of Iowa 2007
UAB School of Health Professions - Member of "Fab 40" - 2009
Sam Brown Bridge Builder Award, UAB, 2010
President, International Society for Clinical Densitometry, 2011-2012

Research Interests

Dr. Morgan's research program has been focused on methotrexate and folic acid metabolism in patients with rheumatoid arthritis.  Her work with Dr. Joseph E Baggott and members of the Division of Clinical Immunology and Rheumatology (Drs. Graciela Alarcon, Dr. William Koopman, Dr. S Louis Bridges, and Dr. Laura Hughes) have established the folic acid supplementation during low dose methotrexate therapy for rheumatoid arthritis lowers toxicity without affecting efficacy.  Drs Morgan and Baggott have also studied purine metabolism and methotrexate therapy in rat adjuvant arthritis and participate in trials related to methotrexate pharmacogenetics.  Dr. Morgan and Dr. Baggott have also investigated the effects of a medical food on osteoarthritis.

As the Medical Director of the UAB Osteoporosis Prevention and Treatment Clinic, Dr. Morgan has an interest in bone densitometry and clinical trials related to osteoporosis. 


Click here for a more complete list of publications. Below are selected papers.

Morgan SL, Prater GL. 2017 Quality in dual-energy X-ray absorptiometry scans. Bone. 2017 Jan 31. [Epub ahead of print] PMID: 28159711

Lewiecki EM, Binkley N, Morgan SL, Shuhart CR, Camargos BM, Carey JJ, Gordon CM, Jankowski LG, Lee JK, Leslie WD. 2016. Best practices for dual-energy x-ray absorptiometry measurement and reporting: International Society for Clinical Densitometry Guidance. J Clin Densitom 10: 127-40. PMID: 27020004

Baggott JE, Bridges SL, Morgan SL.  2005. Evidence for two phenotypes in the metabolism of methotrexate to 7-hydroxymethotrexate in patients with rheumatoid arthritis.  Arthritis Rheum 52: 356-358. PMID: 15641087

Morgan SL, Baggott JE, Vaughn WH, Austin JS, Veitch TA, Lee JY, Koopman WJ, Krumdieck CL, Alarcón GS. 1994. Supplementation with folic acid during methotrexate therapy of rheumatoid arthritis: results from a double-blind, placebo-controlled trial.  Ann Intern Med 121: 833-841. PMID:7978695

Morgan SL, Baggott JE, Vaughn WH, Young PK, Austin JV, Krumdieck CL, Alarcón GS.  1990. The effect of folic acid supplementation on the toxicity of low-dose methotrexate treatment of rheumatoid arthritis.  Arthritis Rheum 33:  9-18. PMID: 2405864